The Effect of Race/Ethnicity on the Outcome of Highly Active Antiretroviral Therapy for Human Immunodeficiency Virus Type 1–Infected Patients
Citations Over TimeTop 11% of 2002 papers
Abstract
We performed a population-based cohort study to assess the impact of nonwhite origin on the outcome of highly active antiretroviral therapy (HAART) for a Danish cohort of human immunodeficiency virus (HIV)-infected patients. A total of 389 whites and 135 nonwhites started receiving HAART before 1 April 2001. After 1 year of treatment, 78% of nonwhites and 76% of whites achieved a virus load of <500 HIV RNA copies/mL. No major differences were found between the 2 groups with respect to achievement of a virus load of <500 copies/mL (relative risk [RR], 0.94; 95% confidence interval [CI], 0.74-1.18), risk of clinical progression (RR, 0.63; 95% CI, 0.32-1.24), or response measured by total CD4+ cell count. One year after fulfilling Danish recommendations for initiation of HAART, 91% of nonwhites and 93% of whites had started receiving HAART. Race and ethnic origin play no major role in the outcome associated with HAART if access to health care is free.
Related Papers
- → ASSOCIATION BETWEEN BIOLOGICAL PROPERTIES OF HUMAN IMMUNODEFICIENCY VIRUS VARIANTS AND RISK FOR AIDS AND AIDS MORTALITY(1989)578 cited
- → XANTHOMAS AND HYPERLIPIDEMIA IN A HUMAN IMMUNODEFICIENCY VIRUS-INFECTED CHILD RECEIVING HIGHLY ACTIVE ANTIRETROVIRAL THERAPY(2002)15 cited
- → Immunopathology and pathogenesis of human immunodeficiency virus infection(1991)14 cited
- Withdrawal of Mycobacterium avium complex suppressive therapy in HIV-1-infected patients on highly active antiretroviral therapy.(1999)
- Splenectomy and prognosis of HIV infection. Group d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA)(1996)